Found: 32
Select item for more details and to access through your institution.
Systemic Mastocytosis: Molecular Landscape and Implications for Treatment.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2021, v. 13, n. 1, p. 1, doi. 10.4084/MJHID.2021.046
- By:
- Publication type:
- Article
A quantitative transcriptome reference map of the normal human brain.
- Published in:
- Neurogenetics, 2014, v. 15, n. 4, p. 267, doi. 10.1007/s10048-014-0419-8
- By:
- Publication type:
- Article
Synthesis of Novel Tryptamine Derivatives and Their Biological Activity as Antitumor Agents.
- Published in:
- Molecules, 2021, v. 26, n. 3, p. 683, doi. 10.3390/molecules26030683
- By:
- Publication type:
- Article
Transport of Functionally Appropriate Tools by Capuchin Monkeys ( Cebus apella).
- Published in:
- American Journal of Primatology, 2012, v. 74, n. 3, p. 199, doi. 10.1002/ajp.21987
- By:
- Publication type:
- Article
Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-0204-7
- By:
- Publication type:
- Article
Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP Zaire ebolavirus Vaccine to Inform Marburg Virus and Sudan ebolavirus Vaccines.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1446, doi. 10.3390/vaccines10091446
- By:
- Publication type:
- Article
Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 13, p. 7093, doi. 10.3390/ijms22137093
- By:
- Publication type:
- Article
The Role of Hypoxic Bone Marrow Microenvironment in Acute Myeloid Leukemia and Future Therapeutic Opportunities.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 13, p. 6857, doi. 10.3390/ijms22136857
- By:
- Publication type:
- Article
Recent Advances in the Molecular Biology of Systemic Mastocytosis: Implications for Diagnosis, Prognosis, and Therapy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 11, p. 3987, doi. 10.3390/ijms21113987
- By:
- Publication type:
- Article
MPN-180: A Novel Mechanism of Action of Midostaurin in Systemic Mastocytosis: Beyond KIT Inhibition.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S356, doi. 10.1016/S2152-2650(21)01823-1
- By:
- Publication type:
- Article
CML-182: SETD2 Loss of Function Induces Genomic Instability in CML and May Contribute to Disease Progression to Blast Crisis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S329, doi. 10.1016/S2152-2650(21)01772-9
- By:
- Publication type:
- Article
AML-269: The Anti-Leukemic Effects of the Pan-Aurora Inhibitor Tozasertib Are Negatively Influenced by Hypoxia in Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S297, doi. 10.1016/S2152-2650(21)01708-0
- By:
- Publication type:
- Article
Poster: MPN-180: A Novel Mechanism of Action of Midostaurin in Systemic Mastocytosis: Beyond KIT Inhibition.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S233, doi. 10.1016/S2152-2650(21)01468-3
- By:
- Publication type:
- Article
Poster: CML-182: SETD2 Loss of Function Induces Genomic Instability in CML and May Contribute to Disease Progression to Blast Crisis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S225, doi. 10.1016/S2152-2650(21)01419-1
- By:
- Publication type:
- Article
Poster: AML-269: The Anti-Leukemic Effects of the Pan-Aurora Inhibitor Tozasertib Are Negatively Influenced by Hypoxia in Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S215, doi. 10.1016/S2152-2650(21)01351-3
- By:
- Publication type:
- Article
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02363-9
- By:
- Publication type:
- Article
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00468-7
- By:
- Publication type:
- Article
Network integration of multi-tumour omics data suggests novel targeting strategies.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-06992-7
- By:
- Publication type:
- Article
Distinct profile of CD34+ cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive disease.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-020-01776-8
- By:
- Publication type:
- Article
Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor Cells.
- Published in:
- Stem Cells, 2024, v. 42, n. 1, p. 42, doi. 10.1093/stmcls/sxad075
- By:
- Publication type:
- Article
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia.
- Published in:
- Journal of Oncology, 2019, p. 1, doi. 10.1155/2019/5985923
- By:
- Publication type:
- Article
Enabling a New Way of Working through Inclusion and Social Media: A Case Study.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.901132
- By:
- Publication type:
- Article
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.728613
- By:
- Publication type:
- Article
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1654, doi. 10.3390/cancers11111654
- By:
- Publication type:
- Article
Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia.
- Published in:
- OncoTargets & Therapy, 2022, v. 15, p. 103, doi. 10.2147/OTT.S289306
- By:
- Publication type:
- Article
Expanding the phenotype of Brunner syndrome from childhood to adulthood: Description of the second pediatric patient and his mother.
- Published in:
- American Journal of Medical Genetics. Part A, 2024, v. 194, n. 1, p. 82, doi. 10.1002/ajmg.a.63413
- By:
- Publication type:
- Article
Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells.
- Published in:
- Oncology Reports, 2020, v. 44, n. 4, p. 1561
- By:
- Publication type:
- Article
Effects of Psychological Intervention in Glycemic Control of Patients with Type 2 Diabetes in Integrated Primary Care Setting.
- Published in:
- 2018
- By:
- Publication type:
- letter
Aneuploidy: Cancer strength or vulnerability?
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 1, p. 8, doi. 10.1002/ijc.31718
- By:
- Publication type:
- Article